Pluri Inc. (PLUR)
Data as of , from SEC Form 4 filings.
See up to 3 months of PLUR. The 7-day demo opens the 1M and 3M ranges and puts PLUR on your watchlist.
Start 7-day demoLatest PLUR insider trades
About Pluri Inc. (PLUR)
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
- HAIFA
- 113
- 1991
- XNAS
PLUR Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 2 | 211,569 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
PLUR insider transactions (Form 4)
2916 Form 4 filings on record, the earliest from Jul 1, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Doron Shorrer - Director | Grant or award | Common Stock | 31,569 footnote F1 | $0.00 | - | |
| ||||||
| Alexandre Weinstein Manieu - Director | Grant or award | Common Shares | 180,000 footnote F1 | $0.00 | - | |
| ||||||
| Alexandre Weinstein Manieu - Director | Grant or award | Common Stock | 641 | $0.00 | - | |
| Alexandre Weinstein Manieu - Director | Other | Warrants | 625,000 | $0.00 | - | |
| Alexandre Weinstein Manieu - Director | Grant or award | Common Stock | 312,500 | $2.00 footnote F5 | $625K | |
| Alexandre Weinstein Manieu - Director | Grant or award | Common Stock | 312,500 | $2.00 footnote F5 | $625K | |
| Alexandre Weinstein Manieu - Director | Grant or award | Warrants | 312,500 | $2.00 | $625K | |
| Alexandre Weinstein Manieu - Director | Grant or award | Warrants | 312,500 | $2.00 | $625K | |
| ||||||
| Alexandre Weinstein Manieu - Director | Grant or award | Common Stock | 625,000 | $2.00 | $1.25M | |
| Alexandre Weinstein Manieu - Director | Grant or award | Warrants | 625,000 | $2.00 | $1.25M | |
| Alexandre Weinstein Manieu - Director | Grant or award | Common Stock | 519 footnote F1 | $0.00 | - | |
| ||||||
| Eitan Ajchenbaum - Director | Grant or award | Common Stock | 668 footnote F1 | $0.00 | - | |
| ||||||
 Yaky Yanay - Officer | Grant or award | Common Stock | 6,588 footnote F1 | $0.00 | - | |
| ||||||
| Rami Avraham Levi - Director | Grant or award | Common Stock | 653 footnote F1 | $0.00 | - | |
| ||||||
| Liat Zalts - Officer | Grant or award | Common Stock | 3,660 | $0.00 | - | |
| Maital Shemesh-Rasmussen - Director | Grant or award | Common Stock | 699 footnote F1 | $0.00 | - | |
| ||||||
| Zami Aberman - Director | Grant or award | Common Stock | 346 footnote F1 | $0.00 | - | |
| ||||||
| Alexandre Weinstein Manieu - Director | Option exercise | Pre-Funded Warrants to purchase Common Shares | 1,002,169 footnote F3 | $0.00 footnote F7 | - | |
| Alexandre Weinstein Manieu - Director | Grant or award | Common Warrants | 84,599 footnote F4 | $0.00 footnote F7 | - | |
| Alexandre Weinstein Manieu - Director | Grant or award | Common Stock | 10,250 | $0.00 | - | |
| Alexandre Weinstein Manieu - Director | Option exercise | Common Stock | 1,002,169 | $0.00 | $100 | |
| Alexandre Weinstein Manieu - Director | Open-market purchase | Common Stock | 452,702 | $4.61 | $2.09M | |
| ||||||
| Eitan Ajchenbaum - Director | Grant or award | Common Stock | 11,685 | $0.00 | - | |
| Yaky Yanay - Officer | Grant or award | Common Stock | 39,050 footnote F1 | $0.00 | - | |
| Yaky Yanay - Officer | Grant or award | Stock Option | 39,050 | $0.00 | - | |
| ||||||
| Alexandre Weinstein Manieu - Director | Open-market purchase | Common Stock | 523,437 | $4.61 | $2.41M | |
| Alexandre Weinstein Manieu - Director | Open-market purchase | Common Stock | 452,702 | $4.61 | $2.09M | |
| Alexandre Weinstein Manieu - Director | Other | Common Stock | 976,139 | - | - | |
| Alexandre Weinstein Manieu - Director | Other | Pre-Funded Warrants to purchase Common Shares | 976,139 | - | - | |
Item 1.01, 3.02, 9.01
Item 8.01
Item 8.01
Item 3.01
PLUR insider trading FAQ
What is the latest insider trade for PLUR?
Pluri Inc. (PLUR) had 2 insider filings in the last 90 days, with the most recent on 2026-08-24. The full record for PLUR runs to 16 Form 4 filings, the earliest from 2025-07-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PLUR stock?
No insider purchases of PLUR were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling PLUR stock?
No insider sales of PLUR were filed in the last 90 days.
Where can I see PLUR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PLUR Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Doron Shorrer view on EDGAR
- - Alexandre Weinstein Manieu view on EDGAR
- - Alexandre Weinstein Manieu view on EDGAR
- - Alexandre Weinstein Manieu view on EDGAR
- - Alexandre Weinstein Manieu view on EDGAR
- - Alexandre Weinstein Manieu view on EDGAR
- - Eitan Ajchenbaum view on EDGAR
- - Yaky Yanay view on EDGAR
- - Rami Avraham Levi view on EDGAR
- - Liat Zalts
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where PLUR's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PLUR with a 7-day demo
- PLUR on your watchlist
- Every PLUR Form 4 filing on record
- Up to 3 months of PLUR price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
